Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Xu, H Eric

Class:IdPerson:5654852
_displayNameXu, H Eric
_timestamp2014-12-04 00:03:50
created[InstanceEdit:5654849] Amarasinghe, Vindhya, 2014-12-04
firstnameH Eric
initialHE
surnameXu
(author)[LiteratureReference:5654798] DWARF 53 acts as a repressor of strigolactone signalling in rice
[LiteratureReference:6792767] Ion channels gated by acetylcholine and serotonin: structures, biology, and drug discovery
[LiteratureReference:8937594] Structural basis for hormone recognition by the Human CRFR2{alpha} G protein-coupled receptor
[LiteratureReference:8937612] Molecular recognition of corticotropin-releasing factor by its G-protein-coupled receptor CRFR1
[LiteratureReference:8948277] Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition
[LiteratureReference:8948322] Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor
[LiteratureReference:9610506] A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity
[LiteratureReference:9697280] Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
[LiteratureReference:9860045] Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma
[LiteratureReference:9860624] Structural and biochemical basis for the binding selectivity of peroxisome proliferator-activated receptor gamma to PGC-1alpha
[Change default viewing format]
No pathways have been reviewed or authored by Xu, H Eric (5654852)